Patient P-02139
Synthetic patientMETA-24 · Day 173 · 55–64 · F · baseline S17Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
22%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S17
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Nutritional resilience-11
- GI instability+6
- Treatment adherence+3
- Inflammatory activity+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable69 min
worsening · -5.9 vs previous 14 d
Sleep duration
Wearable4.6 h
stable · -0.2 vs previous 14 d
Energy level
Daily log5/10
worsening · -0.5 vs previous 14 d
Steps
Wearable7,205
stable · -177 vs previous 14 d
GI burden
Companion21.6/100
worsening · +2.3 vs previous 14 d
Adherence
Companion93.3 %
stable · +1.0 vs previous 14 d
Sleep quality
Wearable23/100
worsening · -4.4 vs previous 14 d
Glucose, CGM daily mean
CGM141 mg/dL
stable · +3.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 80 from the failing basin, 7 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -4.8 next day on high-intake days · n 22
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-4.8supporter · 95%
- Histamine load-2.1no signal · 43%
- Simple carbohydrates+2no signal · 46%
- Alcohol+1.9no signal · 36%
- Dietary fat load-1.2no signal · 22%
- Caffeine-0.7no signal · 15%
- Ultra-processed food+0.5no signal · 15%
- Insoluble fibre+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓45
- WearableResting HR 75 bpm
- WearableShort sleep window
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
- Mucosal barrier integrity ↓10
- WearableSleep 4.6 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
Microbiome
Shannon diversity 3.5 · butyrate capacity 65/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 63 ms
- Sleep
- 5.8 h
- Steps
- 6,790
- Resting HR
- 73 bpm
Daily log: GI score 22, nutritional resilience 62, adherence 93.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.